Journal ArticleDOI
Synthesis and Structure−Activity Relationship of a New Series of Potent AT1 Selective Angiotensin II Receptor Antagonists: 5-(Biphenyl-4-ylmethyl)pyrazoles
TLDR
Compound 14n, a new series of 5-(biphenyl-4-ylmethyl)pyrazoles as potent angiotensin II antagonists, shows high potency both in vitro and in vivo and is selection for clinical evaluation as an antihypertensive agent.Abstract:
The synthesis and pharmacological activity of a new series of 5-(biphenyl-4-ylmethyl)pyrazoles as potent angiotensin II antagonists both in vitro (binding of [3H]AII) and in vivo (iv, inhibition of AII-induced increase in blood pressure, pithed rats; po, furosemide-treated sodium-depleted rats) are reported. The various substituents of the pyrazole ring have been modified taking into account the receptor's requirements derived from related structure−activity relationship studies. A propyl or butyl group at position 1 as well as a carboxylic acid group at position 4 were shown to be essential for high affinity. Different groups at position 3 (H, small alkyl, phenyl, benzyl) provided good binding affinity, but oral activity was highly discriminating: bulky alkyl groups provided the highest potencies. Among the acidic isosteres tested in the biphenyl moiety, the tetrazole group proved to be the best. Compound 14n (3-tert-butyl-1-propyl-5-[[2‘-(1H-tetrazol-5-yl)-1,1‘-biphenyl-4-yl]methyl]-1H-pyrazole-4-carbo...read more
Citations
More filters
Journal ArticleDOI
Ionic liquids in heterocyclic synthesis.
TL;DR: Ionic Liquids Presented in This Review 2020 3.1.
Journal ArticleDOI
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
TL;DR: Although there is general consensus that a continuous receptor blockade over a 24-hour period is desirable, the clinical relevance of other pharmacological differences between individual ARBs remains to be assessed.
Journal ArticleDOI
Multi-objective de novo drug design with conditional graph generative model
TL;DR: In this article, a new de novo molecular design framework is proposed based on a type of sequential graph generators that do not use atom level recurrent units, which has been scaled up to cover significantly larger molecules in the ChEMBL database.
Journal ArticleDOI
Synthesis of Pyrazoles via Electrophilic Cyclization
TL;DR: Iodocyclization was general for a wide range of α,β-alkynic hydrazones and tolerated the presence of aliphatic, aromatic, heteroaromatic, and ferrocenyl moieties with electron-withdrawing and electron-donating substituents.
Journal ArticleDOI
Preparation of 3,5-Disubstituted Pyrazoles and Isoxazoles from Terminal Alkynes, Aldehydes, Hydrazines, and Hydroxylamine
TL;DR: The reaction of terminal alkynes with n-BuLi, and then with aldehydes, followed by the treatment with molecular iodine, and subsequently hydrazines or hydroxylamine provided the corresponding 3,5-disubstituted pyrazoles or isoxazoles in good yields with high regioselectivity through the formations of propargyl secondary alkoxides and α-alkynyl ketones.
References
More filters
Journal ArticleDOI
The Palladium-Catalyzed Cross-Coupling Reaction of Phenylboronic Acid with Haloarenes in the Presence of Bases
TL;DR: The transition metal-catalyzed reactions of organometallics with organic halides have been extensively studied to prove a new approach to selective formation of carbon-carbon bonds as mentioned in this paper.
Journal ArticleDOI
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
David J. Carini,J V Duncia,Paul E. Aldrich,Andrew T. Chiu,Alexander L. Johnson,Michael E. Pierce,William A. Price,J B Santella rd,Gregory J. Wells,Ruth R. Wexler +9 more
TL;DR: A new series of nonpeptide angiotensin II (AII) receptor antagonists has been prepared, and it has been found that the acidic group at the 2'-position of the biphenyl is essential.
Journal ArticleDOI
Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase
TL;DR: HPLC analysis showed that ACE cleaved SP at Phe8-Gly9 and Gly9-Leu10 to release C-terminal tri- and dipeptide (ratio = 4:1) indicating an active site arginine is required for hydrolysis of SP.
Journal ArticleDOI
Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy
Ruth R. Wexler,William J. Greenlee,John D. Irvin,Michael Goldberg,Kristine Prendergast,Ronald D. Smith,Pieter B.M.W.M. Timmermans +6 more
Related Papers (5)
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
T. D. Penning,John J. Talley,Bertenshaw,Jeffery S. Carter,P. W. Collins,Stephen H. Docter,Matthew J. Graneto,Len F. Lee,James W. Malecha,Julie M. Miyashiro,Roland S. Rogers,D. J. Rogier,Stella S. Yu,AndersonGD,E. G. Burton,J. N. Cogburn,Susan A. Gregory,Carol M. Koboldt,W E Perkins,Karen Seibert,A. W. Veenhuizen,Yan Y. Zhang,P. C. Isakson +22 more